CASE REPORT article
Follicular Conjunctivitis due to Chlamydia felis—Case Report, Review of the Literature and Improved Molecular Diagnostics
- 1Augenklinik, Universitätsklinikum Erlangen, Erlangen, Germany
- 2Mikrobiologisches Institut, Klinische Mikrobiologie, Immunologie und Hygiene, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany
A 29-year-old woman presented with unilateral, chronic follicular conjunctivitis since 6 weeks. While the conjunctival swab taken from the patient’s eye was negative in a Chlamydia (C.) trachomatis-specific PCR, C. felis was identified as etiological agent using a pan-Chlamydia TaqMan-PCR followed by sequence analysis. A pet kitten of the patient was found to be the source of infection, as its conjunctival and pharyngeal swabs were also positive for C. felis. The patient was successfully treated with systemic doxycycline. This report, which presents one of the few documented cases of human C. felis infection, illustrates that standard PCR tests are designed to detect the most frequently seen species of a bacterial genus but might fail to be reactive with less common species. We developed a modified pan-Chlamydia/C. felis duplex TaqMan-PCR assay that detects C. felis without the need of subsequent sequencing. The role of chlamydiae-specific serum antibody titers for the diagnosis of follicular conjunctivitis is discussed.
Follicular conjunctivitis is characterized by conjunctival hyperemia and lymphoid follicle formation on the conjunctiva of the eyelid, which causes irritation and a red eye, often with symptoms for several weeks. A chronic follicular inflammation of the conjunctiva can be sign of a bacterial or viral infection (1). Chlamydiae are special agents, because they are obligate intracellular bacteria and cannot be cultured on standard media. Therefore, microbiological routine diagnostics relies mainly on DNA-based PCR tests that are used for detection of these bacteria in thoroughly taken, cell-containing conjunctival swabs (2). Nearly all cases of chlamydial conjunctivitis are caused by Chlamydia (C.) trachomatis (serotypes D to K), generally in the context of a genital infection. C. felis, an agent of the feline “cat flue” syndrome, is a known, but rare agent of human follicular conjunctivitis with five documented cases (3–7). The role of C. psittaci and C. pneumoniae in follicular conjunctivitis is less established because only isolated cases have been reported (6, 8).
Here, we report a human case of follicular conjunctivitis due to C. felis with clear evidence for transmission from a pet cat, discuss the limitations of laboratory diagnostics, and offer a newly developed real-time PCR method for the specific detection of C. felis.
A 29-year-old woman presented to our outpatient clinic with a history of a reddish, swollen left eye for 6 weeks (Figure 1). She reported to suffer from severe irritation of the eye with purulent discharge in the morning. The patient was otherwise healthy and did not use any medication. She did not report any previous eye infections, systemic diseases or ophthalmologic treatments. From time to time she has used artificial tear fluids to treat a mild dry eye syndrome. The dry eye symptoms were aggravated by the daily computer work during her office job. About two months ago, she had adopted two pet kittens (cat 1 and cat 2) from an animal shelter. Whereas cat 1 soon had died from severe “cat-flu,” cat 2 was rather healthy showing only mild conjunctivitis. The patient remembered that cat 2 had sneezed into her left eye prior to the onset of her disease manifestations.
Ophthalmological examination of the patient revealed a best corrected visual acuity of 20/20 on both eyes. A follicular inflammation of the conjunctiva tarsi of the upper and lower lid of the left eye as well as a mild conjunctivitis on the right eye was found (Figure 1). The cornea of both eyes was unaffected; in particular, there were no signs of scarification or edema. There was also no evidence for an intraocular inflammation, and the retina and vitreous body were without pathological findings. Microbiological cultures of conjunctival swabs taken from both eyes yielded the growth of normal bacterial flora, but not of pathogenic bacteria or of fungi. A serum sample of the patient showed only low-level titers of antibodies against the genus Chlamydia, consistent with a previous chlamydial infection. Another conjunctival swab taken from the left eye was used for molecular microbiological diagnostics. The C. trachomatis-specific PCR was negative, but C. felis-DNA was detected using a pan-Chlamydia PCR/sequencing approach (Figure 2). The diagnosis was confirmed by PCR-based detection of a second C. felis-specific gene sequence (hflX).
Figure 2. Amplification plots of real-time PCR assays. C. trachomatis PCR (A–D), pan-Chlamydia PCR (E–H), and new pan-Chlamydia/C. felis duplex PCR assay (I–L) on the conjunctival swab from the patient (A,E,I), conjunctival swab from the cat (B,F,J), and throat swab from the cat (C,G,K). (D,H) Positive controls. Results (+, positive; −, negative) are given within the panels for internal control (IC, black), C. trachomatis (Ct, green), pan-Chlamydia PCR (Cs, blue), and the pan-Chlamydia/C. felis duplex PCR (Cs/Cf) containing both the genus-specific (Cs, blue) and the C. felis-specific probe (Cf, red). (L) Specificity controls of the new pan-Chlamydia/C. felis duplex PCR showing positive results with the genus-specific probe (green, black, and blue), but no cross-reactivity of the C. felis-specific probe (red). Three reactions are combined in one panel: DNA from C. psittaci (Cps, cell culture, 105 infection forming units per PCR), C. pneumoniae (Cpn, cell culture, 2 × 104 genomic copies per PCR), and C. trachomatis (Ct, from urethral swab specimen, 4 × 103 infection forming units per PCR).
To verify that the patient’s kitten (cat 2) was the source of infection, swabs from the throat and conjunctiva of the cat were tested, yielding again positive results in the pan-Chlamydia PCR; the subsequent sequence analysis of the PCR product led to unambiguous identification of C. felis (Figure 2).
After therapy with azithromycin eye drops (twice daily for 3 days) and subsequent systemic therapy with doxycycline (100 mg twice daily for 14 days), symptoms and clinical signs initially improved in our patient. However, after discontinuation of the antibiotic treatment, the conjunctival inflammation relapsed requiring a second 14 days-cycle of doxycycline treatment (as above) leading to a complete regression of the follicular conjunctivitis. Dexamethasone eye drops (five times daily for 5 weeks) were prescribed. The cat was also treated with systemic tetracycline to avoid a re-infection of the patient.
Laboratory Diagnostic Tests and Results
Cultures from conjunctival swabs were performed according to microbiological standard procedures on blood agar, chocolate agar and ENDO agar (37°C) as well as on Sabouraud agar (28°C) for 2 days (2). Only few colonies of coagulase-negative staphylococci were obtained.
Indirect Immunofluorescence Assay
Chlamydia microimmunofluorescence test (FOCUS Diagnostics, Cypress, USA) was used for detection of combined IgG and IgM. The test contains antigens from C. pneumoniae, C. trachomatis, and C. psittaci, but does not include C. felis. In the patient’s serum antibodies reactive with all three Chlamydia species were found (titer: 1:40 each, cutoff 1:20).
Isolation of DNA
The patient’s conjunctival swab used for molecular diagnostics was sent to the laboratory in 1 ml of Mastazyme® Chlamydia transport medium (Mast Diagnostica, Reinfeld, Germany). DNA was prepared from 200 µl transport medium using the High Pure PCR Preparation Kit (Roche Diagnostics, Mannheim, Germany). Prior to DNA preparation, 150,000 copies of bacteriophage Lambda DNA (New England Biolabs, Frankfurt, Germany) were added to the sample for internal inhibition control. Swabs taken from the cat’s throat and conjunctiva were treated identically.
Real-time PCR for C. trachomatis and Chlamydia Species
Real-time PCR for specific detection of C. trachomatis cryptic plasmid was performed as described by Jaton et al. (9). TaqMan® Gene Expression Master Mix (Life Technologies, Darmstadt, Germany) was used for PCR with 50 cycling steps (15 s 95°C and 1 min 60°C each) on a StepOne® PCR System (Life Technologies, Darmstadt, Germany). Amplification of bacteriophage Lambda DNA indicated absence of PCR inhibitors for the three tested specimens, but no C. trachomatis DNA was detected (Figures 2A–C).
Pan-Chlamydia PCR for detection of an 23S rRNA gene fragment of Chlamydia spp. was performed under the same conditions as C. trachomatis PCR, but primers (TQF, TQR) and probe TQP were used as described (10). The conjunctival swabs from the patient and her cat as well as the throat swab from the cat tested positive for Chlamydia species (Figures 2E–G). Subsequent sequence analysis revealed the same sequence for all three specimens (identical to GenBank NR_076260, bp 516–646). Blast analysis identified the respective bacteria unambiguously as C. felis.
A modification of the pan-Chlamydia PCR including C. felis-specific probe “CFP” (VIC-TTAGCTTTTTCGAAAGCAATGGTT-NFQ-MGB) was developed in this study (Figure 3). Using both probes (TQP and CFP) in the same PCR reaction, C. felis was detected in the conjunctival swab of the patient as well as in the two samples of the cat (Figures 2I–K) without any shift in sensitivity compared to PCR with TQP alone (Figures 2E–G). 12 copies of a positive control plasmid per PCR reaction reliably gave a positive result (not shown). The species-specificity of the C. felis probe was tested by analyzing the three pathogenic Chlamydiae most frequently found in humans: C. trachomatis, C. psittaci, and C. pneumoniae (Figure 2L). Even in the presence of high amounts of DNA of these chlamydial species, the C. felis-PCR did not yield a positive signal.
Figure 3. 23S rRNA gene fragment as target for the pan-Chlamydia PCR. The primers (TQF and TQR) are highlighted in yellow, and the pan-Chlamydia probe (TQP) in green. The DNA sequence used as C. felis-specific probe (this study) is underlined. Note that despite the overlap of the two probes, there is no interference in detection because they bind to complementary DNA strands. 44 bp of conserved sequences are blanked out (marked by #). GenBank accession numbers for the aligned sequences are: C. felis (NR_076260, bp 516–646), C. trachomatis (NR_103960), C. psittaci (NR_102574), C. pneumoniae (NR_076161), C. avium (NR_121988), C. abortus (NR_077001), C. caviae (NR_076195), C. pecorum (NR_103180), C. muridarum (NR_076163).
Analysis of the C. felis hflX Gene Sequence
To further prove the identity of C. felis detected in the patient and her cat, we attempted to amplify additional C. felis genes according to a published multilocus sequence typing approach (11). Presumably due to the low amount of chlamydial DNA and the accompanying host DNA, we only succeeded in the amplification of the hflx gene in the DNA prepared from the conjunctival swab of the patient (primers YPhflX5: GCTTCTARRGTACTTTTAAATG and YPhflX6: ATWTTAGAGATCTTTGCTAGYCG). The respective sequence (460 bp) was identical to the hflX gene from C. felis Fe/C-56 (GenBank AP006861, bp 883,438–883,897) and C. felis 11E3-3 (GenBank HE795925) and differed in 1 bp from a third reported C. felis sequence (11E3-2, GenBank HE795924). This result confirms the identification of C. felis, showing 65 bp difference to C. caviae (GenBank AE015925) as the fourth matching sequence.
Taxonomy of Chlamydia felis
The pathogen known as C. felis today was originally termed “feline pneumonitis agent” following its first isolation from cats with upper respiratory tract disease (12). Later, the feline chlamydial isolates were grouped into the species Chlamydia psittaci (13). The separation of Chlamydiae into two genera (Chlamydia and Chlamydophila) on the basis of 16S rRNA sequences (14) led to the species “Chlamydophila felis,” which, however, was never accepted by the scientific community and caused some confusion (14, 15). Meanwhile, the proposal to reunify all Chlamydiae into one genus (Chlamydia) has been published (16).
Serology in Chlamydia Diagnostics
In the case of chlamydial infections the diagnostic value of serology is hampered by several obstacles: (1) antibodies against different Chlamydia species show a high degree of cross-reactivity; (2) a high seroprevalence is found in the community as a consequence of frequent upper respiratory tract or genital infections with C. pneumoniae or C. trachomatis; and (3) the intracellular habitat of the pathogen and the mostly locally restricted epithelial infection may lead to limited antibody production (2). Therefore, in cases of uncomplicated genital infection or follicular conjunctivitis due to C. trachomatis, serological testing is not recommended. To assess the value of the immunofluorescence assay for cases of conjunctivitis by C. trachomatis, we retrospectively analyzed the serological results that were available for 24 out of the 32 cases diagnosed in our laboratory by PCR from conjunctival swabs (Table S1 in Supplementary Material). The antibody titers were highly indicative for C. trachomatis infection in 11 cases; consistent with C. trachomatis infection but showing high cross-reactive titers in 4 cases; and not indicative for a C. trachomatis infection in 9 cases. Thus, in uncomplicated cases of C. trachomatis infection such as conjunctivitis serological testing is able to confirm some cases, but is definitely not the method of choice because of its insufficient specificity and sensitivity. Negative serology does not rule out infection, and high titers still require confirmation by PCR.
To date, there is no immunofluorescence assay available for the diagnosis of human C. felis infections. In addition, antibody production in response to C. felis may be lower compared to C. trachomatis, because in general the infection will only affect the ocular conjunctiva, i.e., concurrent genital infection will not be present. In the case of our patient, low titers of cross-reactive, pan-Chlamydia antibodies, compatible with previous chlamydial infections, were detected. However, as C. felis antigen is not included in the microimmunofluorescence assay, definitive statements on the extent of anti-C. felis antibody responses cannot be made.
Direct Detection of Chlamydiae
As Chlamydiae cannot be cultivated on standard cell-free media, they are traditionally detected by microscopical examination of stained clinical specimens or cell cultures. These procedures are laborious and need great experience. As the specificity is dependent on the staining protocol and sensitivity is lower compared to PCR (2, 17), we did not apply these techniques in our case.
Molecular Detection of Chlamydia DNA
As PCR protocols show an outstanding sensitivity for detection of Chlamydiae in clinical specimens, they have almost completely replaced microscopic and cell culture procedures in routine diagnostics (2, 17). Another milestone was the development of real-time PCR protocols with the “closed-tube concept,” i.e., the tubes remain closed after PCR, thereby reducing the risk of DNA contaminations. The high sensitivity and specificity of the real-time PCR even allows screening of young women in low prevalence collectives for inapparent genital C. trachomatis infections (18).
The high specificity of PCR protocols always bears the risk of false negative results if mutations in the target sequence occur. To ensure the detection of putative, new plasmid variants of C. trachomatis, we routinely tested samples by a pan-Chlamydia PCR in addition to the C. trachomatis-specific PCR. In the case described here, the pan-Chlamydia PCR led to the detection of C. felis. As the identification of the respective species with this procedure needs laborious sequencing of the PCR product, we included a new C. felis-specific probe, which directly indicates the presence of C. felis by an additional separate amplification curve. This pan-Chlamydia/C. felis duplex PCR assay showed an unaltered performance for detection of any Chlamydia species (Figures 2E–K), whereas the C. felis-specific probe showed no cross-reactivity to other chlaymidae (Figure 2L) and succeeded in detection of C. felis in the patient’s and the cat’s specimens without any problem. The amplified region of the 23S rRNA gene seems to be invariable within C. felis, as all five sequences present in GenBank show the same sequence as also found in our patient and her cat. In addition, even if such a hypothetical variant existed, it would still be detected by the pan-Chlamydia probe. Species identification would then have to be done by sequence analysis of the PCR product, but with the pan-Chlamydia/C. felis duplex PCR, no chlamydial species can be missed. Thus, we believe that this method is a valuable and reliable tool for modern diagnostic laboratories.
C. felis Infections in Cats and Humans
C. felis causes conjunctivitis and upper respiratory tract infections in cats, particularly kittens, and can be isolated in up to 30% of affected cats. Coinfections with other agents like feline herpesvirus 1, feline calicivirus, Bordetella bronchiseptica, and Mycoplasma felis lead to the “cat flu” syndrome (19, 20). In healthy cats, prevalence of C. felis is lower than 3% (21). Transmission within the cat population occurs through close contact, and ocular fluids are the most important source of infection. C. felis may also be spread by sneezing, which apparently was the route of transmission to our patient. C. felis is probably adapted to cats as its natural host, which offers an explanation that humans are not readily susceptible to infection unless they are exposed to high pathogen loads as it might occur by direct sneezing into a patient’s eye.
Case reports on human infections by C. felis do not indicate that immunosuppression is a prerequisite for infection (Table 1). Our patient also did not suffer from any underlying disease. In general, acute conjunctivitis is a frequent human condition, with an estimated six million cases per year in the USA and Chlamydiae being the cause in 1.8–5.6% of all cases (1). However, only few human cases of C. felis conjunctivitis have been reported (Table 1), despite its high incidence in cats and the large number of pet cats in our society. In our hospital setting, 697 conjunctival swab samples were tested for C. trachomatis conjunctivitis within a 7 year period (unpublished results); 32 cases of C. trachomatis were identified. Out of the 697 specimens, 554 were in parallel tested by a pan-Chlamydia-PCR, but only 1 case of C. felis was found. These findings strongly suggest that the incidence of C. felis as cause of human conjunctivitis (one of 554 patients, i.e., 0.2%) is much lower than that of C. trachomatis (32 of 697 cases, i.e., 4.7%), but also underline the need for a reliable and simple method for the detection of C. felis as described above (see Molecular Detection of Chlamydia DNA).
In accordance with previous case reports (see Table 1), our patient was successfully treated with doxycycline. Tetracyclines are also the drugs of choice in Chlamydia-infected cats, in which 4 weeks of therapy are recommended to achieve pathogen elimination (20).
C. felis is a rare agent of chronic follicular conjunctivitis in humans and is acquired by close contact to infected cats via ocular fluid or sneezing. Patients with follicular conjunctivitis should be questioned about contact to cats, and if the patient’s conjunctival swab tested negative for C. trachomatis by PCR, the diagnostic laboratory should be asked to perform additional tests for Chlamydiae other than C. trachomatis or to transfer the specimen to a specialized laboratory. Chlamydia-infected pet animals are a potential source of infection for humans and therefore should receive curative antibiotic treatment.
The written informed consent was obtained from the patient.
JW, RM, and AB obtained the patient’s clinical history and performed the medical examination and the treatment. CB substantially contributed to the acquisition of specimens from the cat and to analysis and interpretation of results. WG conducted the entire laboratory diagnostics and developed the respective assays. WG, JW, and CB wrote the manuscript. AB and RM critically revised the paper. All the authors have approved the final version of the manuscript for publication and agreed to be responsible for their part of the work.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The authors are grateful to Dr. med. vet. H. Grenzmann for obtaining the conjunctival and throat swabs from the patient’s cat. The authors thank Prof. E. Straube (Jena, Germany) and Dr. M. Maaß (Lübeck, Germany) for kindly providing the cell cultures of C. psittaci and C. pneumoniae.
The research of this work was supported by funds of the Institute of Clinical Microbiology, Immunology and Hygiene.
The Supplementary Material for this article can be found online at https://www.frontiersin.org/article/10.3389/fmed.2017.00105/full#supplementary-material.
5. Darougar S, John AC, Viswalingam M, Cornell L, Jones BR. Isolation of Chlamydia psittaci from a patient with interstitial keratitis and uveitis associated with otological and cardiovascular lesions. Br J Ophthalmol (1978) 62:709–14. doi:10.1136/bjo.62.10.709
6. Lietman T, Brooks D, Moncada J, Schachter J, Dawson C, Dean D. Chronic follicular conjunctivitis associated with Chlamydia psittaci or Chlamydia pneumoniae. Clin Infect Dis (1998) 26:1335–40. doi:10.1086/516373
7. Hartley JC, Stevenson S, Robinson AJ, Littlewood JD, Carder C, Cartledge J, et al. Conjunctivitis due to Chlamydophila felis (Chlamydia psittaci feline pneumonitis agent) acquired from a cat: case report with molecular characterization of isolates from the patient and cat. J Infect (2001) 43:7–11. doi:10.1053/jinf.2001.0845
11. Pannekoek Y, Dickx V, Beeckman DS, Jolley KA, Keijzers WC, Vretou E, et al. Multi locus sequence typing of Chlamydia reveals an association between Chlamydia psittaci genotypes and host species. PLoS One (2010) 5:e14179. doi:10.1371/journal.pone.0014179
13. Moulder JM, Hatch TP, Kuo C-C, Schachter J, Storz J. Genus I. Chlamydia Jones, Rake and Stearns 1945, 55. 1st ed. In: Krieg NR, Holt JG, editors. Bergey’s Manual of Systematic Bacteriology. Baltimore, London: Lippincott Williams & Wilkins (1984). p. 729–39.
14. Everett KD, Bush RM, Andersen AA. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol (1999) 49(Pt 2):415–40. doi:10.1099/00207713-49-2-415
15. Schachter J, Stephens RS, Timms P, Kuo C, Bavoil PM, Birkelund S, et al. Radical changes to chlamydial taxonomy are not necessary just yet. Int J Syst Evol Microbiol (2001) 51:249; author reply 251–243. doi:10.1099/00207713-51-1-249
16. Sachse K, Bavoil PM, Kaltenboeck B, Stephens RS, Kuo CC, Rossello-Mora R, et al. Emendation of the family Chlamydiaceae: proposal of a single genus, Chlamydia, to include all currently recognized species. Syst Appl Microbiol (2015) 38:99–103. doi:10.1016/j.syapm.2014.12.004
20. Gruffydd-Jones T, Addie D, Belak S, Boucraut-Baralon C, Egberink H, Frymus T, et al. Chlamydophila felis infection. ABCD guidelines on prevention and management. J Feline Med Surg (2009) 11:605–9. doi:10.1016/j.jfms.2009.05.009
Keywords: Chlamydia felis, Chlamydia trachomatis, follicular conjunctivitis, eye infection, cat flu, PCR
Citation: Wons J, Meiller R, Bergua A, Bogdan C and Geißdörfer W (2017) Follicular Conjunctivitis due to Chlamydia felis—Case Report, Review of the Literature and Improved Molecular Diagnostics. Front. Med. 4:105. doi: 10.3389/fmed.2017.00105
Received: 13 April 2017; Accepted: 28 June 2017;
Published: 17 July 2017
Edited by:Marc Thilo Figge, Leibniz-Institute for Natural Product Research and Infection Biology, Germany
Reviewed by:Julius Schachter, University of California, San Francisco, United States
Carole L. Wilson, Medical University of South Carolina, United States
Florian Tagini, Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland
Copyright: © 2017 Wons, Meiller, Bergua, Bogdan and Geißdörfer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Walter Geißdörfer, email@example.com
†Present address: Juliana Wons, Stadtspital Triemli, Zurich, Switzerland